Oral findings in irradiated edentulous patients
- PMID: 3932235
- DOI: 10.1016/s0300-9785(85)80074-0
Oral findings in irradiated edentulous patients
Abstract
11 edentulous patients (mean age 71.2 years) with oral or oropharyngeal malignancies were examined clinical and microbiologically before, during, and after receiving tumoricidal radiation doses (26.4-74 Gy) towards the head and neck regions. The effect of a supervised oral hygiene program and a saliva substitute (Va-OraLube) was studied. The 9 patients who survived the observation period, showed increased xerostomia and mucositis related to increased radiation. Radionecrosis or oral infections were not observed. The patients wore their dentures throughout the observation period and preferred to use the saliva substitute. The initial number of acidophilic bacteria was high, Candida albicans were present in low numbers and enteric bacteria occurred more frequently than normally. There was a reduction of micro-organisms after introduction of the hygiene program. It is concluded that careful planning of the radiotherapy, pre-radiation oral examination, denture control and instruction and an effective oral hygiene program are essential for the reduction of oral complications in edentulous patients receiving tumoricidal radiotherapy to the head and neck regions.
Similar articles
-
Xerostomia management in the head and neck radiation patient.Tex Dent J. 2004 Jun;121(6):483-97. Tex Dent J. 2004. PMID: 15354667 No abstract available.
-
A clinical trial of a novel emulsion for potential use as a saliva substitute in patients with radiation-induced xerostomia.J Oral Rehabil. 2017 Nov;44(11):889-895. doi: 10.1111/joor.12545. Epub 2017 Aug 20. J Oral Rehabil. 2017. PMID: 28741683 Clinical Trial.
-
Oral complications at 6 months after radiation therapy for head and neck cancer.Oral Dis. 2017 Nov;23(8):1134-1143. doi: 10.1111/odi.12710. Epub 2017 Aug 3. Oral Dis. 2017. PMID: 28675770 Free PMC article.
-
Saliva substitutes for the treatment of radiation-induced xerostomia--a review.Support Care Cancer. 2009 Nov;17(11):1331-43. doi: 10.1007/s00520-009-0671-x. Epub 2009 Jun 4. Support Care Cancer. 2009. PMID: 19495809 Review.
-
Managing complications of radiation therapy in head and neck cancer patients: Part I. Management of xerostomia.Singapore Dent J. 2006 Dec;28(1):1-3. Singapore Dent J. 2006. PMID: 17378333 Review.
Cited by
-
Do microorganisms play a role in irradiation mucositis?Eur J Clin Microbiol Infect Dis. 1990 Dec;9(12):861-3. doi: 10.1007/BF01967499. Eur J Clin Microbiol Infect Dis. 1990. PMID: 2073895 No abstract available.
-
Oral mucositis and selective elimination of oral flora in head and neck cancer patients receiving radiotherapy: a double-blind randomised clinical trial.Br J Cancer. 2003 Apr 7;88(7):1012-6. doi: 10.1038/sj.bjc.6600824. Br J Cancer. 2003. PMID: 12671696 Free PMC article. Clinical Trial.
-
Topical application of honey in the management of radiation mucositis: a preliminary study.Support Care Cancer. 2003 Apr;11(4):242-8. doi: 10.1007/s00520-003-0443-y. Epub 2003 Feb 19. Support Care Cancer. 2003. PMID: 12673463 Clinical Trial.
-
Topical curcumin can inhibit deleterious effects of upper respiratory tract bacteria on human oropharyngeal cells in vitro: potential role for patients with cancer therapy induced mucositis?Support Care Cancer. 2011 Jun;19(6):799-806. doi: 10.1007/s00520-010-0894-x. Epub 2010 May 14. Support Care Cancer. 2011. PMID: 20467756
-
Evaluating the effectiveness of topical application of natural honey and benzydamine hydrochloride in the management of radiation mucositis.Indian J Palliat Care. 2012 Sep;18(3):190-5. doi: 10.4103/0973-1075.105689. Indian J Palliat Care. 2012. PMID: 23439942 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Medical